trial

A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease

NCTId NCT03582137
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 74 (actual)
Sponsored by University of Colorado, Denver
Primary completion 2022-01-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
74 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2018-09-05
Primary completion
2022-01-04
Eligibility
ALL · 40 Years · 85 Years

Interventions & indications

Drugs
Cannabidiol

Sponsors

University of Colorado, DenverLead Sponsor
Colorado Department of Public Health and EnvironmentCollaborator

Investigators

1
Maureen LeeheyPrincipal Investigator

Sites

1 total
Aurora, United States

Linked catalysts

1
A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkins — primary completion2022-01-04

Facts & assertions

4 sourced
Enrollment
74
Phase
PHASE2
Primary Completion Date
2022-01-04
Status
COMPLETED
relationships
The graph out of here
drug
Cannabidiol
drug
lead_sponsor
University of Colorado, Denver
company
collaborator
Colorado Department of Public Health and Environment
company
indication
Tremor
indication
Psychotic Disorders
indication
Marijuana Abuse
indication
investigator
Maureen Leehey
person